Tue, 11 May 2021 11:59:10: Ginkgo lands on Nasdaq via $17.5B SPAC merger, giving it billions to fuel growth 

Tue, 11 May 2021 08:34:38: Nuvalent bags $135M to trial resistance-beating kinase inhibitors in lung cancer

Tue, 11 May 2021 06:19:13: Lilly, MiNA ink broad deal to upregulate proteins using RNA

Mon, 10 May 2021 18:39:17: COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals

Mon, 10 May 2021 14:25:36: Attacking aging and chronic disease by eliminating 'senescent' cells with immunotherapy

Mon, 10 May 2021 12:20:16: Bayer's near-approval Farxiga rival meets goal in 2nd phase 3

Mon, 10 May 2021 01:02:59: Flagship debuts Laronde to develop RNA-based meds that could turn cells into protein factories

Fri, 07 May 2021 14:17:38: Daiichi Sankyo, AstraZeneca's $5B Enhertu follow-up shows early signs of success in breast cancer

Fri, 07 May 2021 13:50:22: Gene therapy biotech Gyroscope finds unnavigable seas on IPO market

Fri, 07 May 2021 10:49:22: Adcomm experts split on whether to approve ChemoCentryx's avacopan

Fri, 07 May 2021 10:07:57: Galapagos cuts pipeline, targets €150M in savings after setbacks

Fri, 07 May 2021 08:15:38: Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B

Fri, 07 May 2021 08:02:31: CRISPR therapeutics, Nkarta pen new cutting-edge cancer tech research pact

Thu, 06 May 2021 21:21:13: Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery

Thu, 06 May 2021 12:49:53: Merck takes $170M charge on abandoned COVID-19 drug

Thu, 06 May 2021 12:11:08: Bluebird names oncology spinoff, establishes leadership team

Thu, 06 May 2021 10:08:28: A cancer vaccine built from stem cells? Stanford candidate shows promise in pancreatic tumors

Thu, 06 May 2021 07:52:59: Novavax shares in the red after vaccine sees 51% efficacy against South African COVID variant

Thu, 06 May 2021 03:25:53: Dyno grabs $100M to expand tech, build team, ink more gene therapy partnerships

Wed, 05 May 2021 12:15:26: ChemoCentryx's stock sinks as FDA flags issues with pivotal data

Wed, 05 May 2021 12:01:07: Expelling cancer by squeezing out rogue cells

Wed, 05 May 2021 09:08:22: Perlmutter named CEO of Eikon, a biotech with $148M to apply Nobel-winning tech to undruggable targets

Tue, 04 May 2021 12:57:43: Pfizer halts BCMA trial amid safety woes, hit by DMD delay

Tue, 04 May 2021 11:55:06: Lilly takes variant-busting COVID-19 antibody into the clinic

Tue, 04 May 2021 08:00:18: Novartis loses 2nd oncology R&D exec as Hammerman leaves through the door left open by Engelman